PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform

Author's Avatar
Dec 15, 2022

%3Cb%3EPAVmed+Inc.%3C%2Fb%3E (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that its majority-owned digital health subsidiary Veris Health Inc. (“Veris”), has commercially launched its Veris Cancer Care Platform™ (“Veris CCP”). Veris executed its first commercial contract with New+Jersey+Cancer+Care%2C+PA (“NJCC”), a leading oncology practice and member of the prestigious Quality+Cancer+Care+Alliance.